Praxis Investment Management Inc. Lowers Stake in Procter & Gamble Company (The) $PG

Praxis Investment Management Inc. lessened its position in shares of Procter & Gamble Company (The) (NYSE:PG) by 1.2% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 62,706 shares of the company’s stock after selling 730 shares during the period. Procter & Gamble makes up 0.6% of Praxis Investment Management Inc.’s portfolio, making the stock its 23rd biggest position. Praxis Investment Management Inc.’s holdings in Procter & Gamble were worth $9,990,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. Kingstone Capital Partners Texas LLC grew its holdings in shares of Procter & Gamble by 655,209.0% during the 2nd quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company’s stock worth $11,832,680,000 after purchasing an additional 76,017,350 shares during the period. Northern Trust Corp grew its stake in Procter & Gamble by 0.8% during the first quarter. Northern Trust Corp now owns 29,644,000 shares of the company’s stock worth $5,051,930,000 after buying an additional 248,792 shares during the period. Price T Rowe Associates Inc. MD grew its stake in Procter & Gamble by 13.0% during the first quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company’s stock worth $3,660,737,000 after buying an additional 2,466,308 shares during the period. Goldman Sachs Group Inc. boosted its position in Procter & Gamble by 3.5% during the 1st quarter. Goldman Sachs Group Inc. now owns 17,405,539 shares of the company’s stock worth $2,966,252,000 after purchasing an additional 583,629 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in Procter & Gamble by 6.3% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 17,293,428 shares of the company’s stock worth $2,947,146,000 after purchasing an additional 1,018,865 shares during the period. Hedge funds and other institutional investors own 65.77% of the company’s stock.

Procter & Gamble Trading Up 1.4%

Shares of PG opened at $149.50 on Friday. Procter & Gamble Company has a one year low of $146.96 and a one year high of $180.43. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.49 and a current ratio of 0.70. The company has a market capitalization of $349.90 billion, a P/E ratio of 22.96, a P/E/G ratio of 3.91 and a beta of 0.36. The stock has a 50-day moving average price of $154.96 and a 200 day moving average price of $158.97.

Procter & Gamble (NYSE:PG) last released its quarterly earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, topping analysts’ consensus estimates of $1.42 by $0.06. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The business had revenue of $20.89 billion during the quarter, compared to the consensus estimate of $20.79 billion. During the same quarter last year, the company earned $1.40 earnings per share. The business’s quarterly revenue was up 1.7% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Sell-side analysts forecast that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.

Procter & Gamble Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, November 17th. Stockholders of record on Friday, October 24th will be given a dividend of $1.0568 per share. The ex-dividend date of this dividend is Friday, October 24th. This represents a $4.23 annualized dividend and a dividend yield of 2.8%. Procter & Gamble’s dividend payout ratio (DPR) is presently 64.98%.

Insider Buying and Selling at Procter & Gamble

In other Procter & Gamble news, COO Shailesh Jejurikar sold 13,039 shares of the stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total transaction of $2,050,643.53. Following the transaction, the chief operating officer owned 28,036 shares of the company’s stock, valued at $4,409,221.72. This trade represents a 31.74% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Marc S. Pritchard sold 9,849 shares of the firm’s stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total value of $1,548,952.23. Following the transaction, the insider owned 182,422 shares in the company, valued at $28,689,507.94. This trade represents a 5.12% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 149,763 shares of company stock valued at $23,421,279. Corporate insiders own 0.20% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on the company. Bank of America decreased their target price on Procter & Gamble from $180.00 to $174.00 and set a “buy” rating for the company in a research report on Wednesday, October 8th. Evercore ISI restated an “in-line” rating and issued a $170.00 price target (down previously from $190.00) on shares of Procter & Gamble in a report on Monday, July 14th. Berenberg Bank upped their price target on Procter & Gamble from $152.00 to $154.00 and gave the stock a “hold” rating in a report on Wednesday, September 17th. BNP Paribas Exane decreased their price target on Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating for the company in a report on Tuesday, September 23rd. Finally, UBS Group decreased their target price on shares of Procter & Gamble from $180.00 to $176.00 and set a “buy” rating for the company in a research note on Wednesday, October 8th. Eleven equities research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $172.21.

Procter & Gamble Profile

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.